Pioglitazone vs. Insulin Glargine in the Treatment of Secondary Drug Failure in Type 2 Diabetes
Status:
Completed
Trial end date:
2006-12-01
Target enrollment:
Participant gender:
Summary
Pioglitazone and insulin glargine are equally effective in achieving glycemic control in
secondary drug failure of type 2 diabetes but the mechanisms of actions are different.
Phase:
Phase 4
Details
Lead Sponsor:
Skane University Hospital
Collaborators:
Medical Research Council Skane County Council Research & Development Foundation